| Epigenetic profiling and response to CD19 chimeric antigen receptor T-cell therapy in B-cell malignancies CA Garcia-Prieto, L Villanueva, A Bueno-Costa, V Davalos, ... JNCI: Journal of the National Cancer Institute 114 (3), 436-445, 2022 | 33 | 2022 |
| Validation of the new EPIC DNA methylation microarray (900K EPIC v2) for high-throughput profiling of the human DNA methylome A Noguera-Castells, CA García-Prieto, D Álvarez-Errico, M Esteller Epigenetics 18 (1), 2185742, 2023 | 23 | 2023 |
| Look-alike humans identified by facial recognition algorithms show genetic similarities RS Joshi, M Rigau, CA García-Prieto, MC de Moura, D Piñeyro, S Moran, ... Cell Reports 40 (8), 2022 | 16 | 2022 |
| A Tumor Suppressor Enhancer of PTEN in T-cell Development and Leukemia L Tottone, O Lancho, JW Loh, A Singh, S Kimura, J Roels, A Kuchmiy, ... Blood cancer discovery 2 (1), 92-109, 2021 | 16 | 2021 |
| Epigenetic profiling linked to multisystem inflammatory syndrome in children (MIS-C): A multicenter, retrospective study V Davalos, CA García-Prieto, G Ferrer, S Aguilera-Albesa, ... EClinicalMedicine 50, 2022 | 15 | 2022 |
| Validation of a DNA methylation microarray for 285,000 CpG sites in the mouse genome CA Garcia-Prieto, D Álvarez-Errico, E Musulen, A Bueno-Costa, ... Epigenetics 17 (12), 1677-1685, 2022 | 14 | 2022 |
| Detection of oncogenic and clinically actionable mutations in cancer genomes critically depends on variant calling tools CA Garcia-Prieto, F Martínez-Jiménez, A Valencia, E Porta-Pardo Bioinformatics 38 (12), 3181–3191, 2022 | 12* | 2022 |
| Epigenetic inactivation of the 5-methylcytosine RNA methyltransferase NSUN7 is associated with clinical outcome and therapeutic vulnerability in liver cancer V Ortiz-Barahona, M Soler, V Davalos, CA García-Prieto, M Janin, ... Molecular Cancer 22 (1), 83, 2023 | 9 | 2023 |
| Formaldehyde regulates S-adenosylmethionine biosynthesis and one-carbon metabolism VN Pham, KJ Bruemmer, JDW Toh, EJ Ge, L Tenney, CC Ward, ... Science 382 (6670), eabp9201, 2023 | 8 | 2023 |
| Culture expansion of CAR T cells results in aberrant DNA methylation that is associated with adverse clinical outcome L Salz, A Seitz, D Schäfer, J Franzen, T Holzer, CA Garcia-Prieto, I Bürger, ... Leukemia 37 (9), 1868-1878, 2023 | 6 | 2023 |
| Remodeling of the m6A RNA landscape in the conversion of acute lymphoblastic leukemia cells to macrophages A Bueno-Costa, D Piñeyro, CA García-Prieto, V Ortiz-Barahona, ... Leukemia 36 (8), 2121-2124, 2022 | 6 | 2022 |
| DNA methylation profiling of myelodysplastic syndromes and clinical response to azacitidine: A multicentre retrospective study A Noguera‐Castells, I Campillo‐Marcos, V Davalos, CA García‐Prieto, ... British Journal of Haematology, 2024 | 1 | 2024 |
| Serum DNA methylome of the colorectal cancer serrated pathway enables non‐invasive detection M Gallardo‐Gómez, L Costas‐Ríos, CA Garcia‐Prieto, ... Molecular Oncology, 2023 | 1 | 2023 |
| DNA Methylation-Based Burkitt Lymphoma Epitypes Have Distinct Molecular and Clinical Features N Thomas, K Dreval, DS Gerhard, LK Hilton, JS Abramson, NL Bartlett, ... Blood 140 (Supplement 1), 1734-1736, 2022 | 1 | 2022 |
| Epigenetic Fingerprint of the SARS-CoV-2 Infection in the Lung of Lethal COVID-19 A Noguera-Castells, J Parra, V Davalos, CA García-Prieto, Y Veselinova, ... Chest 165 (4), 820-824, 2024 | | 2024 |
| Abstract P22: PVR (CD155) epigenetic status mediates adoptive cell therapy and anti-TIGIT response in Multiple Myeloma L Martinez-Verbo, L Villanueva, P Llinàs-Arias, CA García-Prieto, ... Blood Cancer Discovery 5 (2_Supplement), P22-P22, 2024 | | 2024 |
| CD155 on Multiple Myeloma Cells Is Epigenetically Regulated, Reduce Patients Survival and Compromises the Action of Novel Immunotherapies L Martinez-Verbo, L Villanueva, P Llinàs-Arias, CA García-Prieto, ... Blood 142, 6567, 2023 | | 2023 |
| Response to Kang et al. CA Garcia-Prieto, V Davalos, M Esteller JNCI: Journal of the National Cancer Institute 115 (10), 1234-1235, 2023 | | 2023 |
| P822: EPIGENETIC REGULATION OF CD155 ON MULTIPLE MYELOMA CELLS INFLUENCES ANTI-TUMOR NOVEL IMMUNOTHERAPEUTIC APPROACHES L Martinez-Verbo, L Villanueva, P Llinàs-Arias, CA García-Prieto, ... HemaSphere 7 (S3), e404615e, 2023 | | 2023 |
| Epigenetic modifications driving ground state pluripotency exit require an NF-κB-independent chromatin IκBα function LG Palma, D Alvarez-Villanueva, M Maqueda, M Barrero, A Iglesias, ... bioRxiv, 2023.07. 28.550934, 2023 | | 2023 |
Manel EstellerDirector, Josep Carreras Leukaemia Research Institute. University of Barcelona and ICREAVerified email at carrerasresearch.org
